Page last updated: 2024-08-23

cefoperazone and cefepime

cefoperazone has been researched along with cefepime in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (9.52)	18.7374
1990's	5 (11.90)	18.2507
2000's	19 (45.24)	29.6817
2010's	10 (23.81)	24.3611
2020's	4 (9.52)	2.80

Authors

Authors	Studies
Jolivette, LJ; Ward, KW	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N	1
Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM	1
Hsiao, YJ; Hu, RM; Huang, KJ; Wu, LT; Yang, TC	1
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ	1
Cai, JC; Chen, GX; Zhang, R; Zhou, HW	1
Lombardo, F; Obach, RS; Waters, NJ	1
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J	1
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH	1
Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R	1
Anderson, KC; Kellogg, GE; Sarkar, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barriere, SL; Johnson, BL; Kalman, D	1
Guiot, HF; Mattie, H; van Furth, R; van Ogtrop, ML	1
Guiot, HF; Hazekamp-van Dokkum, AM; Mattie, H; van Furth, R; van Ogtrop, ML; van Strijen, E	1
Neiderriter, K; Norden, CW	1
Barry, AL; Jones, RN; Packer, RR	1
Bies, M; Buck, RE; Chisholm, DR; Kessler, RE; Leitner, F; Misiek, M; Price, KE; Pursiano, TA; Tsai, YH	1
Barry, AL; Fuchs, PC; Jones, RN; Thornsberry, C	1
Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC	1
Chan, WC; Cheng, AF; Li, RC; Ling, JM; Schentag, JJ	1
Chen, M; Xu, Y; Zhang, S	1
Chen, M; Liu, J; Wang, C; Wang, H; Wang, P; Xie, X; Xu, Y; Yuan, Y; Zhang, X; Zhang, Y	1
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E	1
Beketov, AS; Komarov, RM; Pisarev, VV; Sidorenko, SV	1
Akiyama, K; Endo, H; Hiramatsu, N; Koyama, T; Nishinari, C; Suzuki, Y	1
Lee, WS; Lin, ML; Liu, CY; Wang, FD	1
Huang, JJ; Yu, JL; Zeng, Q	1
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T	1
Alp, E; Aygen, B; Metan, G; Sumerkan, B	1
Beksaç, MS; Katlan, D; Kir, S; Nemutlu, E	1
Beksac, MS; Katlan, D; Kir, S; Nemutlu, E; Ozyuncu, O	1
Tuğrul, HM; Yıldırım, MI	1
Gao, L; Li, Y; Lyu, Y	1
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J	1
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X	1
Chen, YH; Chen, YS; Chuang, YC; Huang, CT; Ko, WC; Lee, WS; Lin, HH; Lin, JC; Liu, JW; Liu, YC; Lu, MC; Tang, HJ; Wang, FD	2
Wu, F; Zhou, X	1
Attwood, M; Bowker, K; MacGowan, A; Noel, A	1
Abdul Momin, MHF; Hornsey, M; Phee, LM; Standing, JF; Wareham, DW	1

Reviews

1 review(s) available for cefoperazone and cefepime

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

4 trial(s) available for cefoperazone and cefepime

Article	Year
[Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:3 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Clinical Trials as Topic; Costs and Cost Analysis; Drug Combinations; Humans; Imipenem; Meropenem; Models, Economic; Sulbactam; Thienamycins	2003
[Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2005, Volume: 25, Issue:9 Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Pneumonia, Bacterial; Sulbactam	2005
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult	2018
Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefoperazone; Drug Therapy, Combination; Female; Haemophilus Infections; Healthcare-Associated Pneumonia; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Sulbactam; Treatment Outcome	2019

Other Studies

37 other study(ies) available for cefoperazone and cefepime

Article	Year
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7 Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal	2007
Biochemical characterization of PER-2 and genetic environment of blaPER-2. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA	2007
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechol 2,3-Dioxygenase; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Stenotrophomonas maltophilia	2008
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary	2008
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei	2009
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea	2010
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation	2010
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics. European journal of medicinal chemistry, 2012, Volume: 52 Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics	2012
Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:2 Topics: Adult; Bacteria; Blister; Body Fluids; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Enterobacter cloacae; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus	1992
Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5 Topics: Animals; Candida albicans; Cecum; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Citrobacter; Feces; Gram-Negative Aerobic Bacteria; Intestines; Mice; Organ Size	1991
Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:10 Topics: Animals; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Female; Mice	1990
In vitro activity of BMY-28142, a new cephalosporin. Chemotherapy, 1987, Volume: 33, Issue:1 Topics: Bacteria; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus	1987
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents. Diagnostic microbiology and infectious disease, 1985, Volume: 3, Issue:3 Topics: Anti-Bacterial Agents; Bacteroides; Cefepime; Cefoperazone; Cefoxitin; Cephalosporins; Cephamycins; Chloramphenicol; Clindamycin; Clostridium; Lactams; Metronidazole; Microbial Sensitivity Tests; Piperacillin	1985
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biological Availability; Blood Proteins; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Mice; Microbial Sensitivity Tests; Moxalactam; Protein Binding	1985
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:5 Topics: Bacteria; beta-Lactamases; Cefepime; Cefoperazone; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Stability; Hydrolysis; Microbial Sensitivity Tests	1985
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group. Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam	1997
Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefamandole; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Enterobacter cloacae; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins	1999
[Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method]. Zhonghua yi xue za zhi, 2000, Volume: 80, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; China; Imipenem; Microbial Sensitivity Tests; Piperacillin	2000
In vitro activity of meropenem and four other antibiotics against 554 clinical strains obtained from Beijing in 1999. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2000, Volume: 6, Issue:3 Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Meropenem; Thienamycins	2000
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics. Oral microbiology and immunology, 2002, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam	2002
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:4 Topics: Cefepime; Cefoperazone; Cefozopran; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Moraxella	2003
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria. International journal of antimicrobial agents, 2004, Volume: 23, Issue:6 Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam	2004
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins	2006
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis. International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey	2007
Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone. Talanta, 2009, Nov-15, Volume: 80, Issue:1 Topics: Amniotic Fluid; Calibration; Cefepime; Cefixime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Molecular Structure; Pregnancy; Reproducibility of Results; Temperature	2009
Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone. International journal of antimicrobial agents, 2010, Volume: 36, Issue:2 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Cefepime; Cefoperazone; Cephalosporins; Female; Fetal Blood; Fluoroquinolones; Humans; Infant, Newborn; Injections, Intravenous; Levofloxacin; Maternal-Fetal Exchange; Moxifloxacin; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Quinolines	2010
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:3 Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh	2011
Trends in Drug Resistance of Chinese medical journal, 2017, Mar-20, Volume: 130, Issue:6 Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2017
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015] Zhonghua wei zhong bing ji jiu yi xue, 2016, Volume: 28, Issue:5 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins	2016
Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam. Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2 Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Healthcare-Associated Pneumonia; Humans; Sulbactam	2020
Reply to Zhou and Wu, "Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam". Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2 Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Healthcare-Associated Pneumonia; Humans; Sulbactam	2020
Comment on: Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections. The Journal of antimicrobial chemotherapy, 2020, 09-01, Volume: 75, Issue:9 Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Sulbactam	2020
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' response. The Journal of antimicrobial chemotherapy, 2020, 09-01, Volume: 75, Issue:9 Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Sulbactam	2020